UK Medicines Information
Use of Medications of Questionable Benefit in Advanced Dementia
Information type:
Other primary research
Source:
JAMA Internal Medicine
Specialities:
Later life | Mental health and illness
Summary
This US study of 5406 nursing home residents with advanced dementia found that over half received at least one medicine with questionable benefit, most commonly cholinesterase inhibitors (36.4%), memantine hydrochloride (25.2%), and lipid-lowering agents (22.4%).
UKMi comment
A Commentary discussing the results of this research is available at the link below.
Related links:
Commentary